Essex Junior Squash is calling upon all of its friends to support our 200 Club, a monthly draw with cash prizes going to lucky winners, a donation to charity and any profits being ploughed back into junior squash development in the county.

Tickets cost just £2 per month per entry number and you can pay by Standing Order to simplify things. There’s no restriction on how many numbers you can purchase. We just ask that if any juniors wish to take part they acquire their numbers through their parents. We’re sure all their winnings will be passed on with a smile.

The 200 Club has monthly prizes of £40, £30 and £20 and we will publish all winning numbers on our website, Twitter and Facebook accounts and the draw will be carried out with at least three independent witnesses.

The idea was launched by The Essex Junior Squash committee in an attempt to cover the financial shortfall suffered when England Squash increased their levy on all players competing in our sanctioned events. The 300 percent rise in fees paid to ES  hit us hard but we were determined to not abandon any of our development projects, which include our Grand Prix series for non-county players, our coaching bursary scheme for developing players, county trials and development coaching.

The Covid19 situation has also meant a dip in income from the 200 Club so were are giving it a New Year push in the hope that people can support us once again.

If you would like to join the 200 Club, email Essex Junior Squash secretary Karen Selby at and she will send you a standing order and entry form.

We are also supporting the charity, Cardiac Risk in the Young. Every week in the UK at least 12 young people die of undiagnosed heart conditions. Since its formation in 1995, Cardiac Risk in the Young (CRY) has been working to reduce the frequency of young sudden cardiac death (YSCD).  CRY supports young people diagnosed with potentially life-threatening cardiac conditions and offers bereavement support to families affected by YSCD. CRY also promotes and develops heart screening programmes and funds medical research.